---
title: "Rajgor Castor Derivatives Ltd (RCDL) — Share Price, Financials & Analysis"
symbol: "RCDL"
company: "Rajgor Castor Derivatives Ltd"
canonical: "https://tapetide.com/stocks/RCDL"
isin: "INE0BZQ01011"
nse_symbol: "RCDL"
sector: "FMCG"
industry: "FMCG Products"
market_cap_cr: 67.92
generated_at: "2026-09-13T19:14:38.209Z"
---

# Rajgor Castor Derivatives Ltd (RCDL)

Canonical page: https://tapetide.com/stocks/RCDL

## Company

- **NSE Symbol:** RCDL
- **ISIN:** INE0BZQ01011
- **Sector:** FMCG
- **Industry:** FMCG Products
- **Macro Sector:** Fast Moving Consumer Goods
- **Stock Type:** EQUITY
- **Listed Since:** 2023-10-31
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** rajgorcastor.com

## About

Incorporated in 2018, Rajgor Castor Derivatives Ltd manufactures & trades Castor Seeds, Castor derivative products, other merchandise etc. and leasing activity[1]

## Latest Price

- **Price:** ₹14.5
- **Change:** +0.1 (+0.69%)
- **Open:** ₹14.95
- **Day High:** ₹14.95
- **Day Low:** ₹14.4
- **Previous Close:** ₹14.4
- **Volume:** 12000
- **As Of:** 2026-09-11T09:59:38+00:00

## Key Fundamentals

Observed at 2026-09-11T04:47:12.960519Z.

- **Market Cap:** ₹67.92 Cr
- **Classification:** SME
- **P/E (reported):** 5.4
- **EPS (reported):** ₹4.09
- **Book Value:** ₹24.94
- **Price to Book:** 0.58
- **Dividend Yield:** 0.7%
- **ROE:** 10.85%
- **ROCE:** 25.29%
- **Debt to Equity:** 0.8
- **Revenue (yearly):** ₹872.2 Cr
- **Net Income:** ₹12.23 Cr
- **EBITDA:** ₹23.25 Cr
- **52-Week High:** ₹35
- **52-Week Low:** ₹13.75
- **RSI (14):** 37.49

## Tapetide Score

- **Score:** 61 / 100
- **Score date:** 2026-09-04
- **Archetype:** No Dominant Pattern
- **What it means:** The three pillars do not combine into a recognisable pattern. Read them individually rather than looking for one story — the lack of a pattern is itself the finding.
- **Pillar profile:** Quality: Average · Valuation: Cheap · Momentum: Falling
- **Percentile:** 90.4 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 38.17 | 9% |
| growth | 85.64 | 9% |
| momentum | 5.93 | 12% |
| ownership | 82.5 | 24% |
| quality | 56.92 | 22% |
| valuation | 62.51 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Stock is trading at 0.73 times its book value
- Company has delivered good profit growth of 55.8% CAGR over last 5 years

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 132.05% | 127.47% | 11.04% |
| ebitda margin growth | -6.98% | -27.52% | -26.11% | -72.32% |
| net income growth | -26.32% | 35.89% | 32% | 56% |
| revenue growth | -30.94% | 39.02% | 27% | 146% |
| roce | — | 4.68% | -26.55% | 22.6% |
| roe | — | -17.68% | 15.82% | -109.02% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 225 | 204 | 191 | 374 | 278 | 347 | 279 | 593 |
| Expenses | 226 | 192 | 182 | 362 | 272 | 332 | 273 | 576 |
| Operating Profit | -1 | 12 | 8 | 12 | 5 | 16 | 6 | 17 |
| OPM % | -0.3 | 6 | 4.3 | 3.2 | 2 | 4.5 | 2.2 | 2.9 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 3 |
| Interest | 1 | 1 | 3 | 3 | 3 | 5 | 3 | 4 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | -2 | 11 | 5 | 9 | 2 | 12 | 2 | 15 |
| Tax % | 23 | 25 | 31 | 27 | 16 | 39 | 24 | 26 |
| Net Profit | -2 | 8 | 3 | 6 | 2 | 7 | 2 | 11 |
| EPS in Rs | -118.5 | 18.4 | 1.12 | 1.34 | 0.36 | 1.53 | 0.34 | 2.3 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 113 | 14 | 10 | 40 | 429 | 565 | 625 | 872 |
| Expenses | 110 | 13 | 10 | 37 | 417 | 545 | 604 | 849 |
| Operating Profit | 2 | 1 | 0 | 3 | 12 | 20 | 21 | 23 |
| OPM % | 2 | 9 | -0.8 | 7 | 2.7 | 3.6 | 3.4 | 2.7 |
| Other Income | 0 | 1 | 1 | 1 | 0 | 0 | 2 | 3 |
| Interest | 1 | 2 | 2 | 2 | 2 | 5 | 8 | 8 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
| Profit before tax | 0 | -1 | -3 | 0 | 9 | 14 | 14 | 17 |
| Tax % | 28 | -25 | -29 | -62 | 36 | 28 | 35 | 26 |
| Net Profit | 0 | -1 | -2 | 1 | 6 | 10 | 9 | 13 |
| EPS in Rs | 18 | -54 | -90 | 26 | 12.88 | 2.05 | 1.88 | 2.64 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 27 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 0.12 | 0.12 | 0.12 | 0.12 | 2 | 24 | 24 | 24 |
| Reserves | 4 | 3 | 1 | 2 | 22 | 50 | 59 | 71 |
| Borrowings | 18 | 19 | 23 | 18 | 45 | 47 | 44 | 76 |
| Other Liabilities | 4 | 4 | 1 | 17 | 10 | 66 | 28 | 106 |
| Total Liabilities | 27 | 27 | 26 | 38 | 78 | 188 | 155 | 277 |
| Fixed Assets | 18 | 22 | 21 | 20 | 20 | 21 | 20 | 20 |
| CWIP | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| Other Assets | 4 | 4 | 4 | 17 | 58 | 165 | 134 | 256 |
| Total Assets | 27 | 27 | 26 | 38 | 78 | 188 | 155 | 277 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 2 | 3 | 0 | 7 | -40 | -34 | 11 | -14 |
| Cash from Investing Activity | -23 | -1 | 0 | 0 | -1 | -4 | 1 | -9 |
| Cash from Financing Activity | 21 | -2 | 0 | -7 | 41 | 38 | -12 | 24 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Free Cash Flow | -20 | 1 | 0 | 7 | -41 | -37 | 10 | -15 |
| CFO/OP | 95 | 226 | 0 | 273 | -348 | -163 | 64 | -45 |

### Ratios

| Item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 0 | 17 | 2 | 2 | 12 | 64 | 47 | 70 |
| Inventory Days | 0 | 3 | 8 | 129 | 17 | 17 | 18 | 17 |
| Days Payable | — | 1 | 4 | 9 | 5 | 30 | 6 | 29 |
| Cash Conversion Cycle | 0 | 20 | 5 | 121 | 25 | 51 | 59 | 58 |
| Working Capital Days | -3 | -24 | -471 | -130 | 7 | 35 | 36 | 26 |
| ROCE % | — | 4 | -1 | 12 | 23 | 20 | 17 | 17 |

## Shareholding Pattern

### Quarterly

| Category | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Promoters | 60.02% | 60.02% | 60.02% | 60.02% | 60.02% |
| FIIs | 3.42% | 3.04% | 3.47% | 3.63% | 4.1% |
| DIIs | 0% | 0% | 0% | 0% | 5.76% |
| Government | 0% | 0% | 0% | 0% | 0% |
| Public | 22.67% | 26.2% | 27.97% | 28.47% | 26.28% |
| Others | 13.89% | 10.73% | 8.53% | 7.87% | 3.84% |
| No. of Shareholders | 807 | 1022 | 991 | 956 | 890 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 4 / 3 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 14.85 | Sell |
| EMA (10) | 15.63 | Sell |
| SMA (20) | 19.06 | Sell |
| EMA (20) | 18.36 | Sell |
| SMA (50) | 24.19 | Sell |
| EMA (50) | 22.17 | Sell |
| SMA (100) | 24.15 | Sell |
| EMA (100) | 23.42 | Sell |
| SMA (200) | 23.52 | Sell |
| EMA (200) | 23.59 | Sell |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 29.08 | Buy |
| MACD (12,26,9) | -3.39 | Sell |
| Stochastic (14,3,3) | 7.55 | Buy |
| ADX (14) | 35.12 | Buy |
| Williams %R (14) | -90.91 | Buy |
| ATR (14) | 1.59 | High Volatility |
| ROC (12) | -19.89 | Sell |
| Stoch RSI (14) | 76.08 | Neutral |
| UO (7,14,28) | 35.46 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 8 Aug - NSE granted in-principle approval for rights issue up to Rs 23.92 crore on August 7, 2026. | [General Updates 8 Aug - NSE granted in-principle approval for rights issue up to Rs 23.92 crore on August 7, 2026.](https://nsearchives.nseindia.com/corporate/RAJGOR_08082026134140_Intimation_Inprinciple_Approval_Sd.pdf) |
| 8 April 2026 - Submitted Regulation 74(5) certificate for quarter ended 31 March 2026. | [Certificate under SEBI (Depositories and Participants) Regulations, 2018 8 April 2026 - Submitted Regulation 74(5) certificate for quarter ended 31 March 2026.](https://nsearchives.nseindia.com/corporate/RAJGOR_08042026174505_RCDL_Reg_74_5__Sd.pdf) |
| 7 Sep - Corrigendum revises rights issue dates: renunciation September 18, closing September 25, allotment October 1, 2026. | [Copy of Newspaper Publication 7 Sep - Corrigendum revises rights issue dates: renunciation September 18, closing September 25, allotment October 1, 2026.](https://nsearchives.nseindia.com/corporate/RAJGOR_07092026182412_Newspaper-Adv_Sd.pdf) |
| 31 Jul - Investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written … | [Price movement 31 Jul - Investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written …](https://www.nseindia.com/companies-listing/corporate-filings-announcements?symbol=RCDL&tabIndex=sme) |
| 31 Jul - Company clarified share price movement on 31 July 2026, stating no undisclosed material event. | [Updates 31 Jul - Company clarified share price movement on 31 July 2026, stating no undisclosed material event.](https://nsearchives.nseindia.com/corporate/RAJGOR_31072026185317_Clarification_Sd.pdf) |
| 3 Sep - Rights issue closing date extended to September 25, 2026; revised timetable announced. | [Committee Meeting Updates 3 Sep - Rights issue closing date extended to September 25, 2026; revised timetable announced.](https://nsearchives.nseindia.com/corporate/RAJGOR_03092026152852_RCM_outcome_Sd.pdf) |
| 3 Sep - Rajgor Castor Derivatives approved rights issue corrigendum; closing September 25, allotment September 28, listing October 1, 2026. | [Updates 3 Sep - Rajgor Castor Derivatives approved rights issue corrigendum; closing September 25, allotment September 28, listing October 1, 2026.](https://nsearchives.nseindia.com/corporate/RAJGOR_03092026182127_Corrigendum_Final_Sd.pdf) |
| 3 February 2026 - Infomerics reaffirmed IVR BBB/Stable for Rs50 crore and IVR A3+ for Rs10 crore (03-Feb-2026). | [Credit Rating 3 February 2026 - Infomerics reaffirmed IVR BBB/Stable for Rs50 crore and IVR A3+ for Rs10 crore (03-Feb-2026).](https://nsearchives.nseindia.com/corporate/RAJGOR_03022026194851_RCDL_CR_Sd.pdf) |
| 29 Aug - Published pre-issue advertisement for 1:1 rights issue of 2.39 crore shares worth Rs 23.92 crore. | [Copy of Newspaper Publication 29 Aug - Published pre-issue advertisement for 1:1 rights issue of 2.39 crore shares worth Rs 23.92 crore.](https://nsearchives.nseindia.com/corporate/RAJGOR_29082026132626_Newspaper_advt_Rights_issue_upload_sd.pdf) |
| 28 April 2026 - Rajgor Castor Derivatives confirms it is not a large corporate for FY2026-27 debt disclosure requirements. | [Updates 28 April 2026 - Rajgor Castor Derivatives confirms it is not a large corporate for FY2026-27 debt disclosure requirements.](https://nsearchives.nseindia.com/corporate/RAJGOR_28042026160624_Covering-Letter_Large-Corporate_Sd.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Annual Report 2025 from nse](https://archives.nseindia.com/annual_reports/SME_AR_28627_RCDL_2024_2025_A_21668284_05092025182756.pdf) |
| from nse | [Annual Report 2024 from nse](https://archives.nseindia.com/annual_reports/SME_AR_25902_RCDL_2023_2024_05092024195122.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:14:38.209Z.